Journal article icon

Journal article

Development of a DNA-MVA/HIVA vaccine for Kenya.

Abstract:

Without going into the details of the devastation that human immunodeficiency virus (HIV) infection causes especially in the developing world, the best hope for changing the course of this epidemic is development of a safe, effective, accessible prophylactic HIV vaccine. While the inaccessibility of potentially neutralising epitopes on primary HIV isolates has hampered the development of envelope-based vaccines, there is a number of new potent technologies capable of inducing high levels of c...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Jenner Institute
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Experimental Medicine Division,
Role:
Author
Expand authors...
Journal:
Vaccine
Volume:
20
Issue:
15
Pages:
1995-1998
Publication date:
2002-05-05
DOI:
EISSN:
1873-2518
ISSN:
0264-410X
URN:
uuid:ec926860-4650-456d-ae5b-faabaa386f43
Source identifiers:
32098
Local pid:
pubs:32098

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP